This is an important observational study which points towards higher mobidity and mortality in patients with acute coronary syndromes who undergo transfusion. The results obtained, though not definitive due to […]
The debate of blood transfusion and cancer recurrence continues in this study. The authors found LN status and >3 units of blood transfused to be poor prognostic factors, but this […]
A nice demonstration again in a placebo controlled trial that recombinant EPO is safe and effective in anemic cancer patients on chemorx. The three times weekly dose is more commonly […]
NATA: Network for the advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and ther healthcare professionals.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.